Literature DB >> 15273720

Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b.

Gareth C Davies1, Seth A Ettenberg, Ashley O Coats, Mark Mussante, Sarangan Ravichandran, Jack Collins, Marion M Nau, Stan Lipkowitz.   

Abstract

Cbl proteins are ubiquitin protein ligases, which ubiquitinate activated tyrosine kinases and target them for degradation. Both c-Cbl and Cbl-b have an ubiquitin associated (UBA) domain at their C-terminal end. We observed that high molecular weight ubiquitinated proteins constitutively coimmunoprecipitated with transfected and endogenous Cbl-b, but not c-Cbl. The binding site for these ubiquitinated proteins was mapped to the UBA domain of Cbl-b (UBAb). GST-fusion proteins containing the UBAb interacted with ubiquitinated proteins and polyubiquitin chains in vitro, whereas those containing the UBA domain of c-Cbl (UBAc) did not. The UBAb had a much greater affinity for polyubiquitin chains than for monoubiquitin. Analysis of the UBAb and UBAc demonstrate that the affinity for ubiquitin is determined by multiple amino-acid differences between the two domains. Overexpression of the UBAb, but not overexpression of the UBAc, inhibited a variety of ubiquitin-mediated processes such as degradation of ubiquitinated proteins (i.e. EGFR, Mdm-2, and Siah-1). This in vivo result is consistent with the differences in ubiquitin binding observed in vitro between the UBAb and UBAc. This difference in ubiquitin-binding may reflect distinct regulatory functions of c-Cbl and Cbl-b.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273720     DOI: 10.1038/sj.onc.1207952

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  41 in total

1.  Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.

Authors:  Scott A Nadeau; Wei An; Bhopal C Mohapatra; Insha Mushtaq; Timothy A Bielecki; Haitao Luan; Neha Zutshi; Gulzar Ahmad; Matthew D Storck; Masashi Sanada; Seishi Ogawa; Vimla Band; Hamid Band
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

2.  Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins.

Authors:  Scott Nadeau; Wei An; Nick Palermo; Dan Feng; Gulzar Ahmad; Lin Dong; Gloria E O Borgstahl; Amarnath Natarajan; Mayumi Naramura; Vimla Band; Hamid Band
Journal:  Biochem Anal Biochem       Date:  2012-07-30

3.  The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site.

Authors:  Bo Chen; Jennifer Mariano; Yien Che Tsai; Anna H Chan; Mickael Cohen; Allan M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

4.  Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.

Authors:  Xavier H Mascle; Mathieu Lussier-Price; Laurent Cappadocia; Patricia Estephan; Luca Raiola; James G Omichinski; Muriel Aubry
Journal:  J Biol Chem       Date:  2013-10-30       Impact factor: 5.157

Review 5.  Strategies to enhance NK cell function for the treatment of tumors and infections.

Authors:  Jacquelyn Freund-Brown; Leilani Chirino; Taku Kambayashi
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 6.  Roles of E3 ubiquitin ligases in cell adhesion and migration.

Authors:  Cai Huang
Journal:  Cell Adh Migr       Date:  2010-01-18       Impact factor: 3.405

Review 7.  Cbl- and Nedd4-family ubiquitin ligases: balancing tolerance and immunity.

Authors:  Denise L Gay; Hilda Ramón; Paula M Oliver
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 8.  The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation.

Authors:  Allan M Weissman; Nitzan Shabek; Aaron Ciechanover
Journal:  Nat Rev Mol Cell Biol       Date:  2011-08-23       Impact factor: 94.444

Review 9.  c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses.

Authors:  Christine B F Thien; Wallace Y Langdon
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

Review 10.  Regulation of immune responses by E3 ubiquitin ligase Cbl-b.

Authors:  Rong Tang; Wallace Y Langdon; Jian Zhang
Journal:  Cell Immunol       Date:  2018-11-07       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.